Is SymBio Pharmaceuticals Limited (4582.T) a Buy, Sell, or Hold?
JPX : 4582.T
SymBio Pharmaceuticals Limited
$70 JPY
$1 (1.45%)
- Volume
- 472.8K
- Average Volume
- 848.14K
- Market Capitalization
- $3.86B
- P/E Ratio
- -0.66
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $229.00
- Year Low
- $65.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.11
Company Overview
JPX
Fuminori Yoshida
Medical - Pharmaceuticals
Healthcare
4582.T
91
JP
JPY
Liquidity Metrics
4.43
1.11
1.04
0.73
0.00
Sales & Valuation
$1.31B
3.02
20.22
0.00
0.00
Profitability
-$95.12
-$4.78B
-458.55%
-456.22%
-424.34%
-198.72%
P/E Metrics
-0.66
0.05
0.05
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-25.02
2/9
$297.26M
$2.95B
$2.72B
-$6.67B
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Edwin Rock | Corporate Officer, Corporate VP and Head of Global R&D Division |
| Masahiko Okuno | Corporate Officer |
| Yoshiharu Torikai | Corporate Officer |
| Minori Rosales | Corporate Officer, CMO Oncology & Neurology and Head of Japan Development Division |
| Hiroyuki Horita | Corporate Officer |
| Fuminori Yoshida | Chief Executive Officer, President & Representative Director |
| Tomonori Seta | Corporate Officer |
Poll Results
No votes yet today — be the first to share your view!
About SymBio Pharmaceuticals Limited (JPX:4582.T) Stock
SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan. ...
Frequently Asked Questions
-
What is the current SymBio Pharmaceuticals Limited (4582.T) stock price?
-
SymBio Pharmaceuticals Limited(JPX:4582.T) stock price is $70 in the last trading session. During the trading session, 4582.T stock reached the peak price of $229 while $65 was the lowest point it dropped to. The percentage change in 4582.T stock occurred in the recent session was 1.45% while the dollar amount for the price change in 4582.T stock was $1.
-
4582.T's industry and sector of operation?
-
The JPX listed 4582.T is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.
-
Who are the executives of 4582.T?
-
Edwin Rock | Corporate Officer, Corporate VP and Head of Global R&D Division
Masahiko Okuno | Corporate Officer
Yoshiharu Torikai | Corporate Officer
Minori Rosales | Corporate Officer, CMO Oncology & Neurology and Head of Japan Development Division
Hiroyuki Horita | Corporate Officer -
How many employees does 4582.T have?
-
Number of 4582.T employees currently stands at 91. 4582.T operates from Toranomon Towers Office, Tokyo, None 105-0001, JP.
-
Link for 4582.T official website?
-
Official Website of 4582.T is: https://www.symbiopharma.com
-
How do I contact 4582.T?
-
4582.T could be contacted at phone #81 3 5472 1125 and can also be accessed through its website. 4582.T operates from Toranomon Towers Office, Tokyo, None 105-0001, JP.
-
How many shares of 4582.T are traded daily?
-
The average number of 4582.T shares traded daily for last 3 months was 848.14K.
-
What is the market cap of 4582.T currently?
-
The market value of 4582.T currently stands at $3.86B with its latest stock price at $70